Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
NTLA US​

Intellia Therapeutics, Inc.(NTLA US)

$11.21+0.050.45%Ext:$11.30+0.090.80%(Market Closed · 23:55:51 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

Financials(44)

Expand
  • 10-QQ2ended 30 Jun 20266 Aug
  • 10-QQ1ended 31 Mar 202611 May
  • 10-KFY 2025ended 31 Dec 202526 Feb
  • 10-QQ3ended 30 Sept 20256 Nov 2025
  • 10-QQ2ended 30 Jun 20257 Aug 2025
  • 10-QQ1ended 31 Mar 20258 May 2025
  • 10-KFY 2024ended 31 Dec 202427 Feb 2025
  • 10-QQ3ended 30 Sept 20247 Nov 2024
  • 10-QQ2ended 30 Jun 20248 Aug 2024
  • 10-QQ1ended 31 Mar 20249 May 2024
  • 10-KFY 2023ended 31 Dec 202322 Feb 2024
  • 10-QQ3ended 30 Sept 20239 Nov 2023
  • 10-QQ2ended 30 Jun 20233 Aug 2023
  • 10-QQ1ended 31 Mar 20234 May 2023
  • 10-QQ3ended 30 Sept 20223 Nov 2022

Events(137)

Expand
  • 8-KRegulation FD Disclosure8 Sep
  • 8-KIntellia Therapeutics SecuresNon-Dilutive4 Sep
  • 8-KResults of Operations and Financial Condition6 Aug
  • 8-KRegulation FD Disclosure15 Jun
  • 8-KSubmission of Matters to a Vote of Security Holders10 Jun
  • 8-KResults of Operations and Financial Condition11 May
  • 8-KEntry into a Material Definitive Agreement30 Apr
  • 8-K*** CONFIDENTIAL ***27 Apr
  • 8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year10 Apr
  • 8-KAMENDMENT NO. 2 TO THE OPEN MARKET SALE AGREEMENTSM2 Mar
  • 8-KResults of Operations and Financial Condition26 Feb
  • 8-KIntellia Therapeutics Announces FDA Lift of Clinical Hold on27 Jan
  • 8-KRegulation FD Disclosure9 Jan
  • 8-KIntellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran10 Nov 2025
  • 8-KIntellia Therapeutics Announces Third Quarter 2025 Financial Results6 Nov 2025

Insider Ownership(350)

Expand
  • 4Statement of changes in beneficial ownership6 Oct
  • 4Statement of changes in beneficial ownership24 Aug
  • 4Statement of changes in beneficial ownership24 Jul
  • 4Statement of changes in beneficial ownership6 Jul
  • 4Statement of changes in beneficial ownership6 Jul
  • 4Statement of changes in beneficial ownership10 Jun
  • 4Statement of changes in beneficial ownership10 Jun
  • 4Statement of changes in beneficial ownership10 Jun
  • 4Statement of changes in beneficial ownership10 Jun
  • 4Statement of changes in beneficial ownership10 Jun
  • 4Statement of changes in beneficial ownership10 Jun
  • 4Statement of changes in beneficial ownership10 Jun
  • 4Statement of changes in beneficial ownership3 Mar
  • 4Statement of changes in beneficial ownership3 Mar
  • 4Statement of changes in beneficial ownership3 Mar

Beneficial Ownership(75)

Expand
  • SC 13GIntellia Therapeutics, Inc.7 Aug
  • SC 13GIntellia Therapeutics, Inc.30 Apr
  • SC 13GIntellia Therapeutics, Inc.29 Apr
  • SC 13G/AIntellia Therapeutics, Inc.27 Mar
  • SC 13G/AIntellia Therapeutics, Inc.12 Feb
  • SC 13G/AIntellia Therapeutics, Inc.11 Feb
  • SC 13GIntellia Therapeutics, Inc.9 Feb
  • SC 13G/AIntellia Therapeutics, Inc.3 Feb
  • SC 13G/AIntellia Therapeutics, Inc.30 Jan
  • SC 13GIntellia Therapeutics, Inc.12 Nov 2025
  • SC 13GIntellia Therapeutics, Inc.12 Nov 2025
  • SC 13G/AIntellia Therapeutics, Inc.4 Nov 2025
  • SC 13GIntellia Therapeutics, Inc.13 May 2025
  • SC 13G/AIntellia Therapeutics, Inc.17 Apr 2025
  • SC 13G/AIntellia Therapeutics, Inc.8 Jan 2025

Other Ownership(9)

Expand
  • 144Clark Eliana5 Oct
  • 144LEONARD JOHN M20 Aug
  • 144Dulac Edward J III2 Jul
  • 144LEONARD JOHN M11 Dec 2025
  • 144Sepp-Lorenzino Laura8 Jan 2024
  • 144Crowley John F7 Dec 2023
  • 144Bhanji Muna31 Jul 2023
  • 144Bhanji Muna6 Jul 2023
  • 144Clark Eliana20 Jun 2023

Proxies(24)

Expand
  • ARSAnnual report to security holders30 Apr
  • DEFA14ADefinitive additional materials30 Apr
  • DEF 14ADefinitive proxy statement30 Apr
  • ARSAnnual report to security holders30 Apr 2025
  • DEFA14ADefinitive additional materials30 Apr 2025
  • DEF 14ADefinitive proxy statement30 Apr 2025
  • ARSAnnual report to security holders29 Apr 2024
  • DEF 14ADefinitive proxy statement29 Apr 2024
  • DEFA14ADefinitive additional materials29 Apr 2024
  • PRE 14APreliminary proxy statement16 Apr 2024
  • DEFA14ADefinitive additional materials5 Jun 2023
  • DEFA14ADefinitive additional materials1 May 2023
  • DEF 14ADefinitive proxy statement1 May 2023
  • ARSAnnual report to security holders18 Apr 2023
  • DEFA14ADefinitive additional materials2 May 2022

Registrations(48)

Expand
  • 424B5Prospectus filing (Rule 424(b)(5))29 Apr
  • 424B5Prospectus filing (Rule 424(b)(5))27 Apr
  • 424B5Prospectus filing (Rule 424(b)(5))2 Mar
  • S-8Registration statement (employee benefit plan)26 Feb
  • S-8Registration statement (employee benefit plan)11 Jun 2025
  • S-8Registration statement (employee benefit plan)28 Feb 2025
  • S-8Registration statement (employee benefit plan)18 Jul 2024
  • 424B5Prospectus filing (Rule 424(b)(5))26 Feb 2024
  • 424B5Prospectus filing (Rule 424(b)(5))23 Feb 2024
  • S-8Registration statement (employee benefit plan)22 Feb 2024
  • S-3ASRAutomatic shelf registration statement (S-3)24 Nov 2023
  • 424B5Prospectus filing (Rule 424(b)(5))4 Mar 2022
  • S-8Registration statement (employee benefit plan)24 Feb 2022
  • 424B5Prospectus filing (Rule 424(b)(5))1 Jul 2021
  • 424B5Prospectus filing (Rule 424(b)(5))28 Jun 2021

Filing Review Correspondence(10)

Expand
  • CORRESPFiling review correspondence10 Sep 2019
  • CORRESPFiling review correspondence30 Aug 2019
  • CORRESPFiling review correspondence4 Jun 2019
  • CORRESPFiling review correspondence15 Jun 2017
  • CORRESPFiling review correspondence3 May 2016
  • CORRESPFiling review correspondence3 May 2016
  • CORRESPFiling review correspondence27 Apr 2016
  • CORRESPFiling review correspondence27 Apr 2016
  • CORRESPFiling review correspondence22 Apr 2016
  • CORRESPFiling review correspondence11 Apr 2016

SEC Orders And Notices(10)

Expand
  • CT ORDERConfidential treatment order1 Sep 2020
  • EFFECTNotice of effectiveness12 Sep 2019
  • EFFECTNotice of effectiveness6 Jun 2019
  • CT ORDERConfidential treatment order9 May 2019
  • CT ORDERConfidential treatment order11 Mar 2019
  • EFFECTNotice of effectiveness16 Jun 2017
  • CT ORDERConfidential treatment order7 Feb 2017
  • CT ORDERConfidential treatment order22 Dec 2016
  • CT ORDERConfidential treatment order6 May 2016
  • EFFECTNotice of effectiveness5 May 2016

Exempt Offerings(1)

Expand
  • D06b3 Sep 2015

Other(1)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT5 May 2016